Mahase V, Sobitan A, Yao Q, Shi X, Qin H, Kidane D
Viruses. 2024; 16(7).
PMID: 39066312
PMC: 11281596.
DOI: 10.3390/v16071150.
Uludag M, Incitti R, Gao X, Heeney J, Gojobori T, Alam I
Bull World Health Organ. 2024; 102(6):374-374A.
PMID: 38828061
PMC: 11132165.
DOI: 10.2471/BLT.22.289528.
Li C, Ma L, Zou D, Zhang R, Bai X, Li L
Genomics Proteomics Bioinformatics. 2023; 21(5):1066-1079.
PMID: 37898309
PMC: 10928372.
DOI: 10.1016/j.gpb.2023.10.004.
Feng Y, Yi J, Yang L, Wang Y, Wen J, Zhao W
Nucleic Acids Res. 2023; 52(D1):D701-D713.
PMID: 37897356
PMC: 10767816.
DOI: 10.1093/nar/gkad958.
Tan M, Xia J, Luo H, Meng G, Zhu Z
Comput Struct Biotechnol J. 2023; 21:4697-4705.
PMID: 37841328
PMC: 10568291.
DOI: 10.1016/j.csbj.2023.09.044.
Analysis of the N-glycosylation profiles of the spike proteins from the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2.
Wang D, Baudys J, Osman S, Barr J
Anal Bioanal Chem. 2023; 415(19):4779-4793.
PMID: 37354227
PMC: 10352417.
DOI: 10.1007/s00216-023-04771-y.
Web Resources for SARS-CoV-2 Genomic Database, Annotation, Analysis and Variant Tracking.
Cheng Y, Ji C, Zhou H, Zheng H, Wu A
Viruses. 2023; 15(5).
PMID: 37243244
PMC: 10222785.
DOI: 10.3390/v15051158.
Modeling SARS-CoV-2 nucleotide mutations as a stochastic process.
Lim Kai Rong M, Kuruoglu E, Chan W
PLoS One. 2023; 18(4):e0284874.
PMID: 37115784
PMC: 10146438.
DOI: 10.1371/journal.pone.0284874.
SARS2Mutant: SARS-CoV-2 amino-acid mutation atlas database.
Rahimian K, Arefian E, Mahdavi B, Mahmanzar M, Kuehu D, Deng Y
NAR Genom Bioinform. 2023; 5(2):lqad037.
PMID: 37101659
PMC: 10124966.
DOI: 10.1093/nargab/lqad037.
Seasonality, mass vaccination and critical policy evaluation on global exit strategy of COVID-19 crisis.
Roy I, Chapungu L, Nyambiya I
Phys Chem Earth (2002). 2023; 130:103388.
PMID: 36923070
PMC: 9985521.
DOI: 10.1016/j.pce.2023.103388.
Molecular characterization and sequecing analysis of SARS-CoV-2 genome in Minas Gerais, Brazil.
Ferreira G, Claro I, Grosche V, Candido D, Jose D, Rocha E
Biologicals. 2022; 80:43-52.
PMID: 36175304
PMC: 9436897.
DOI: 10.1016/j.biologicals.2022.08.001.
Bioinformatics pipeline unveils genetic variability to synthetic vaccine design for Indian SARS-CoV-2 genomes.
Ghosh N, Saha I, Sharma N, Nandi S
Int Immunopharmacol. 2022; 112:109224.
PMID: 36116149
PMC: 9444899.
DOI: 10.1016/j.intimp.2022.109224.
Genetic Surveillance of SARS-CoV-2 M Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid.
Lee J, Yang Q, Gribenko A, Perrin Jr B, Zhu Y, Cardin R
mBio. 2022; 13(4):e0086922.
PMID: 35862764
PMC: 9426535.
DOI: 10.1128/mbio.00869-22.
VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis.
Pinoli P, Bernasconi A, Sandionigi A, Ceri S
BioTech (Basel). 2022; 10(4).
PMID: 35822801
PMC: 9245481.
DOI: 10.3390/biotech10040027.
Bioinformatics for the Origin and Evolution of Viruses.
Chen J, Zhang Y, Shen B
Adv Exp Med Biol. 2022; 1368:53-71.
PMID: 35594020
DOI: 10.1007/978-981-16-8969-7_3.
Neutralizing Effect of Synthetic Peptides toward SARS-CoV-2.
Souza P, vanTilburg M, Mesquita F, Amaral J, Lima L, Montenegro R
ACS Omega. 2022; 7(18):16222-16234.
PMID: 35530749
PMC: 9063117.
DOI: 10.1021/acsomega.2c02203.
Genetic and Structural Analysis of SARS-CoV-2 Spike Protein for Universal Epitope Selection.
Markosian C, Staquicini D, Dogra P, Dodero-Rojas E, Lubin J, Tang F
Mol Biol Evol. 2022; 39(5).
PMID: 35511693
PMC: 9129195.
DOI: 10.1093/molbev/msac091.
The impact of shifting demographics, variants of concern and vaccination on outcomes during the first 3 COVID-19 waves in Alberta and Ontario: a retrospective cohort study.
McAlister F, Nabipoor M, Chu A, Lee D, Saxinger L, Bakal J
CMAJ Open. 2022; 10(2):E400-E408.
PMID: 35473827
PMC: 9121845.
DOI: 10.9778/cmajo.20210323.
Rapid evolution of SARS-CoV-2 challenges human defenses.
Duarte C, Ketcheson D, Eguiluz V, Agusti S, Fernandez-Gracia J, Jamil T
Sci Rep. 2022; 12(1):6457.
PMID: 35440671
PMC: 9017738.
DOI: 10.1038/s41598-022-10097-z.
Inhibitor screening using microarray identifies the high capacity of neutralizing antibodies to Spike variants in SARS-CoV-2 infection and vaccination.
Zhang X, Zheng M, Wang H, Zhou H, Liang T, Zhang J
Theranostics. 2022; 12(6):2519-2534.
PMID: 35401825
PMC: 8965487.
DOI: 10.7150/thno.67038.
